title: Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells.
abstract: Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1alpha, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination-proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
authors.affiliation: Department of Oncology and Hematology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road, Atlanta, GA, USA.
authors.forename: Ceshi
authors.initials: C
authors.lastname: Chen
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Sun
authors.forename: Qimei
authors.initials: Q
authors.lastname: Ran
authors.forename: Keith D
authors.initials: KD
authors.lastname: Wilkinson
authors.forename: T J
authors.initials: TJ
authors.lastname: Murphy
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Simons
authors.forename: Jin-Tang
authors.initials: JT
authors.lastname: Dong
mesh_terms: D015153:Blotting, Western; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D003513:Cycloheximide / Q000494:pharmacology; D004847:Epithelial Cells / Q000378:metabolism*; D006801:Humans; D047468:Immunoprecipitation; D051741:Kruppel-Like Transcription Factors; D008856:Microscopy, Fluorescence; D009369:Neoplasms / Q000378:metabolism; D010957:Plasmids / Q000378:metabolism; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000378:metabolism*; D014162:Transfection; D025801:Ubiquitin / Q000378:metabolism*
chemical_list: C492214:KLF5 protein, human; D051741:Kruppel-Like Transcription Factors; D011500:Protein Synthesis Inhibitors; D015534:Trans-Activators; D025801:Ubiquitin; D003513:Cycloheximide; D046988:Proteasome Endopeptidase Complex